News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CV Risk Remains High After Stopping Vioxx, Yale University School Of Medicine Study


12/15/2010 6:28:03 AM

MedPageToday -- Even after patients stopped taking the painkiller rofecoxib (Vioxx) when it was pulled from the market, their risk of cardiovascular events remained high, researchers reported.

Read at MedPageToday
Read at CNN
Read at New York Times


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES